Utility of multiplex ligation-dependent probe amplification (MLPA) for hemophilia mutation screening

Journal of Thrombosis and Haemostasis

Volumn 10, Issue 9, 2012, Pages 1951-1954

  Payne, A B ^a   Bean, C J ^a   Hooper, W C ^a   Miller, C H ^a  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9;

COPY NUMBER VARIATION; DNA SEQUENCE; GENE DELETION; GENE DUPLICATION; GENE MUTATION; GENETIC CODE; GENETIC SCREENING; HEMOPHILIA A; HEMOPHILIA B; HUMAN; INTRON; LETTER; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; POINT MUTATION; PRIORITY JOURNAL;

ALGORITHMS; HEMOPHILIA A; HUMANS; MULTIPLEX POLYMERASE CHAIN REACTION; MUTATION;

EID: 84865784993     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2012.04843.x     Document Type: Letter

References (12)

1. Soucie JM, Evatt B, Jackson D. Occurrence of hemophilia in the United States. The Hemophilia Surveillance System Project Investigator. Am J Hematol 1998; 59: 288-94.
2. Miller CH, Benson J, Ellingsen D, Driggers J, Payne A, Kelly FM, Soucie JM, Craig Hooper W; The Hemophilia Inhibitor Research Study I. F8 and F9 mutations in US haemophilia patients: correlation with history of inhibitor and race/ethnicity. Haemophilia 2012; 18: 375-82.
3. Peyvandi F, Jayandharan G, Chandy M, Srivastava A, Nakaya SM, Johnson MJ, Thompson AR, Goodeve A, Garagiola I, Lavoretano S, Menegatti M, Palla R, Spreafico M, Tagliabue L, Asselta R, Duga S, Mannucci PM. Genetic diagnosis of haemophilia and other inherited bleeding disorders. Haemophilia 2006; 12(Suppl. 3): 82-9.
4. Klopp N, Oldenburg J, Uen C, Schneppenheim R, Graw J. 11 hemophilia A patients without mutations in the factor VIII encoding gene. Thromb Haemost 2002; 88: 357-60.
5. Rost S, Loffler S, Pavlova A, Muller CR, Oldenburg J. Detection of large duplications within the factor VIII gene by MLPA. J Thromb Haemost 2008; 6: 1996-9.
6. Kwon MJ, Yoo KY, Kim HJ, Kim SH. Identification of mutations in the F9 gene including exon deletion by multiplex ligation-dependent probe amplification in 33 unrelated Korean patients with haemophilia B. Haemophilia 2008; 14: 1069-75.
7. Acquila M, Pasino M, Di Duca M, Bottini F, Molinari AC, Bicocchi MP. MLPA assay in F8 gene mutation screening. Haemophilia 2008; 14: 625-7.
8. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 2002; 30: e57.
9. Oldenburg J, Pavlova A. Genetic risk factors for inhibitors to factors VIII and IX. Haemophilia 2006; 12(Suppl. 6): 15-22.
10. Boekhorst J, Lari GR, D'Oiron R, Costa JM, Novakova IRO, Ala FA, Lavergne JM, van Heerde WL. Factor VIII genotype and inhibitor development in patients with haemophilia A: highest risk in patients with splice site mutations. Haemophilia 2008; 14: 729-35.
11. Margaglione M, Castaman G, Morfini M, Rocino A, Santagostino E, Tagariello G, Tagliaferri AR, Zanon E, Bicocchi MP, Castaldo G, Peyvandi F, Santacroce R, Torricelli F, Grandone E, Mannucci PM; Group AI-GS. The Italian AICE-Genetics hemophilia A database: results and correlation with clinical phenotype. Haematologica 2008; 93: 722-8.
12. Coppola A, Santoro C, Tagliaferri A, Franchini M, Di Minno G. Understanding inhibitor development in haemophilia A: towards clinical prediction and prevention strategies. Haemophilia 2010; 16(Suppl. 1): 13-9.